BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

KuDos Pharmaceutical Limited 

327 Cambridge Science Park
Milton Road
Cambridge    CB4 OWG  United Kingdom
Phone: 44-0-1223-719719 Fax: 44-0-1223-719720


SEARCH JOBS


Industry
Pharmaceutical






 Company News
AstraZeneca (AZN) To Buy Cancer Firm KuDos Pharmaceutical Limited For $210 Million 12/23/2005 10:21:12 AM    More...
Novacea Begins Phase 1/2 Trial of Anti-Cancer Agent Banoxantrone (AQ4N) In Patients With Lymphoma 10/19/2005 5:13:13 PM    More...
Novacea Announces Three Presentations On Anti-Cancer Agent, Banoxantrone (AQ4N), At American Association for Cancer Research Meeting 10/19/2005 5:12:42 PM    More...
Novacea To Present At 46th Annual American Society of Hematology (ASH) Meeting 10/19/2005 5:12:20 PM    More...
KuDos Pharmaceutical Limited Release: AQ4N Well Tolerated In First Phase I Report 10/19/2005 5:11:38 PM    More...
Novacea Licenses Novel Anti-Cancer Product Candidate From KuDos Pharmaceutical Limited 10/19/2005 5:09:29 PM    More...
First Patient Treated With New KuDos Pharmaceutical Limited Oral Anticancer Agent 10/19/2005 5:09:00 PM    More...

//-->